Related references
Note: Only part of the references are listed.Endothelin-converting enzyme-1c promotes stem cell traits and aggressiveness in colorectal cancer cells
Pablo Perez-Moreno et al.
MOLECULAR ONCOLOGY (2020)
Phosphorylation of Endothelin-Converting Enzyme-1c at Serines 18 and 20 by CK2 Promotes Aggressiveness Traits in Colorectal Cancer Cells
Pablo Perez-Moreno et al.
FRONTIERS IN ONCOLOGY (2020)
Endothelin-converting enzyme-1 in cancer aggressiveness
Julio C. Tapia et al.
CANCER LETTERS (2019)
CK2 inhibition with silmitasertib promotes methuosis-like cell death associated to catastrophic massive vacuolization of colorectal cancer cells
Eduardo Silva-Pavez et al.
CELL DEATH & DISEASE (2019)
Extracellular adenosine promotes cell migration/invasion of Glioblastoma Stem-like Cells through A3 Adenosine Receptor activation under hypoxia
Angelo Torres et al.
CANCER LETTERS (2019)
In vivo knockdown of antisense non-coding mitochondrial RNAs by a lentiviral-encoded shRNA inhibits melanoma tumor growth and lung colonization
Manuel Varas-Godoy et al.
PIGMENT CELL & MELANOMA RESEARCH (2018)
Gemcitabine and glioblastoma: challenges and current perspectives
Chiara Bastiancich et al.
DRUG DISCOVERY TODAY (2018)
The Adenosine A3 Receptor Regulates Differentiation of Glioblastoma Stem-Like Cells to Endothelial Cells under Hypoxia
Rene Rocha et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
FK506 Attenuates the MRP1-Mediated Chemoresistant Phenotype in Glioblastoma Stem-Like Cells
Angelo Torres et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
GlioVis data portal for visualization and analysis of brain tumor expression datasets
Robert L. Bowman et al.
NEURO-ONCOLOGY (2017)
Protein kinase CK2 is important for the function of glioblastoma brain tumor initiating cells
Amber L. Rowse et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Expression and function of ABCG2 and XIAP in glioblastomas
Ivette F. Emery et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Multidrug resistance in glioblastoma stem-like cells: Role of the hypoxic microenvironment and adenosine signaling
Daniel Uribe et al.
MOLECULAR ASPECTS OF MEDICINE (2017)
Structural and functional identification of vasculogenic mimicry in vitro
Dusan Racordon et al.
SCIENTIFIC REPORTS (2017)
Role of 14-3-3 sigma in over-expression of P-gp by rifampin and paclitaxel stimulation through interaction with PXR
So Won Kim et al.
CELLULAR SIGNALLING (2017)
Endothelin therapeutics in cancer: Where are we?
Laura Rosano et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2016)
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade
Zhaolin Chen et al.
CANCER LETTERS (2016)
Akt and β-catenin contribute to TMZ resistance and EMT of MGMT negative malignant glioma cell line
Guo-zhong Yi et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2016)
A comprehensive profile of recurrent glioblastoma
B. Campos et al.
ONCOGENE (2016)
Adenosine A3 receptor elicits chemoresistance mediated by multiple resistance-associated protein-1 in human glioblastoma stem-like cells
Angelo Torres et al.
ONCOTARGET (2016)
Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice
Sun-Jin Kim et al.
CLINICAL CANCER RESEARCH (2015)
Casein kinase 2 (CK2) phosphorylates the deubiquitylase OTUB1 at Ser16 to trigger its nuclear localization
Lina Herhaus et al.
SCIENCE SIGNALING (2015)
Cancer Stem Cells: The Promise and the Potential
Jaffer A. Ajani et al.
SEMINARS IN ONCOLOGY (2015)
Colon cancer cell invasion is promoted by protein kinase CK2 through increase of endothelin- converting enzyme-1c protein stability
Ignacio Niechi et al.
ONCOTARGET (2015)
Casein kinase 2 (CK2) phosphorylates the deubiquitylase OTUB1 at Ser16 to trigger its nuclear localization
Lina Herhaus et al.
SCIENCE SIGNALING (2015)
Disrupting the endothelin and Wnt relationship to overcome chemoresistance
Laura Rosano et al.
MOLECULAR & CELLULAR ONCOLOGY (2015)
The search for novel therapeutic strategies in the treatment of recurrent glioblastoma multiforme
Richard M. Bambury et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2014)
Exogenous endothelin-1 induces cell migration and matrix metalloproteinase expression in U251 human glioblastoma multiforme
Wen-Tsong Hsieh et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Remodelling the extracellular matrix in development and disease
Caroline Bonnans et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Cancer stem cells in colorectal cancer from pathogenesis to therapy: Controversies and perspectives
Caterina Fanali et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Endothelin receptor-A is required for the recruitment of antitumor T cells and modulates chemotherapy induction of cancer stem cells
Lan Coffman et al.
CANCER BIOLOGY & THERAPY (2013)
Understanding high grade glioma: Molecular mechanism, therapy and comprehensive management
Yongzhi Wang et al.
CANCER LETTERS (2013)
The Role of Protein Kinase CK2 in Glioblastoma Development
Haitao Ji et al.
CLINICAL CANCER RESEARCH (2013)
Glioblastoma and Other Malignant Gliomas A Clinical Review
Antonio Omuro et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Endothelin 1 in cancer: biological implications and therapeutic opportunities
Laura Rosano et al.
NATURE REVIEWS CANCER (2013)
Protein Kinase C recognition sites in the cytoplasmic domain of Endothelin Converting Enzyme-1c
Sanjaya Kuruppu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Protein Kinase CK2 Promotes Cancer Cell Viability Via Up-Regulation of Cyclooxygenase-2 Expression and Enhanced Prostaglandin E2 Production
Roger Yefi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
CK2 functionally interacts with AKT/PKB to promote the β-catenin-dependent expression of survivin and enhance cell survival
Daniela P. Ponce et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
Overexpression of Nuclear Protein Kinase CK2 α Catalytic Subunit (CK2α) as a Poor Prognosticator in Human Colorectal Cancer
Kai-Yuan Lin et al.
PLOS ONE (2011)
Addiction to protein kinase CK2: A common denominator of diverse cancer cells?
Maria Ruzzene et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2010)
Too much of a good thing: The role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2
James S. Duncan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2008)
Isoforms of endothelin-converting enzyme-1 (ECE-1) have opposing effects on prostate cancer cell invasion
L. A. Lambert et al.
BRITISH JOURNAL OF CANCER (2008)
Small Interfering RNA Molecules Targeting Endothelin-Converting Enzyme-1 Inhibit Endothelin-1 Synthesis and the Invasive Phenotype of Ovarian Carcinoma Cells
Oleg Rayhman et al.
CANCER RESEARCH (2008)
Malignant gliomas in adults
Patrick Y. Wen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Protein and mRNA characterization in human colorectal carcinoma cell lines with different metastatic potentials
Li Liang et al.
CANCER INVESTIGATION (2007)
Casein kinase 2 (CK2) increases survivin expression via enhanced β-catenin-T cell factor/lymphoid enhancer binding factor-dependent transcription
J. C. Tapia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Endothelin-converting enzyme-1 inhibition and growth of human glioblastoma cells
Y Berger et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Share Paper
